Skip to search formSkip to main contentSkip to account menu

ebelactone B

Known as: 2-Oxetanone, 3-ethyl-4-(8-hydroxy-1,3,5,7,9-pentamethyl-6-oxo-3-undecenyl)-, (3S-(3alpha,4beta(1R*,3E,5S*,7R*,8S*,9S*)))-, 2-ethyl-3,11-dihydroxy-4,6,8,10,12-pentamethyl-9-oxo-tetradecenoic 1,3-lactone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
PURPOSE Previous in vitro studies have demonstrated that a potent antihypertensive agent ebelactone B inhibits cathepsin A… 
2000
2000
1. To determine whether the antihypertensive response in deoxycorticosterone acetate (DOCA) salt‐treated rats was mediated by… 
2000
2000
We have previously reported that the renal kallikrein‐kinin system suppressed the development of deoxycorticosterone acetate… 
1999
1999
The effect of prolonged administration of a carboxypeptidase Y‐like kininase inhibitor, ebelactone B (EB) (2‐ethyl‐3, 11… 
1995
1995
Two types of Rhizoctonia solani esterases induced by cutin hydrolysate were partially purified by ammonium sulfate precipitation… 
1994
1994
Ebelactone B (EB) (10(-7)-10(-5) M) inhibited dose-dependently carboxypeptidase (CP) Y-like exopeptidase, one of the major… 
Highly Cited
1992
Highly Cited
1992
Proteins from eucaryotic cells which have a carboxyl-terminal CAAX motif are posttranslationally modified by isoprenylation. The…